J. Carpenter
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Global Cancer Incidence and Screening
Papers in
- Oncology 13
- Cancer Treatment and Pharmacology 12
- Lung Cancer Research Studies 1
-
- Advanced Breast Cancer Therapies 9
- Co-authors
- R. T. Chlebowski (1 shared paper)H.T. Mouridsen (1 shared paper)Aman U. Buzdar (1 shared paper)Andrea Bianco (1 shared paper)Rory Collins (1 shared paper)John Crowley (1 shared paper)Rosalin Cooper (1 shared paper)Francesco Boccardo (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Cancer Research (3 papers)British Journal of Haematology (1 paper)PubMed (8 papers)Journal of Allergy (1 paper)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
J. Carpenter
23 papers receiving 687 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 272
- Oncology 320
- Genetics 199
- Pathology and Forensic Medicine 72
- Pulmonary and Respiratory Medicine 115
Countries citing papers authored by J. Carpenter
This map shows the geographic impact of J. Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Carpenter more than expected).
Fields of papers citing papers by J. Carpenter
This network shows the impact of papers produced by J. Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Carpenter. The network helps show where J. Carpenter may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Carpenter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women | 1988 | 477 |
| 2 | 2005 | 81 | |
| 3 | Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response. | 1986 | 35 |
| 4 | Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: a Southeastern Cancer Study Group trial. | 1986 | 25 |
| 5 | 1964 | 20 | |
| 6 | Use of megestrol acetate in advanced breast cancer on a single-daily-dose schedule. | 1985 | 12 |
| 7 | 2013 | 11 | |
| 8 | Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial. | 1986 | 8 |
| 9 | 2008 | 8 | |
| 10 | Ineffectiveness of levamisole in prolonging remission or survival of women treated with cyclophosphamide, doxorubicin, and 5-fluorouracil for good-risk metastatic breast carcinoma: a Southeastern Cancer Study Group Trial. | 1986 | 6 |
| 11 | Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). | 1975 | 6 |
| 12 | Response to doxorubicin and mitomycin in cholangiocarcinoma: a case report. | 1982 | 4 |
| 13 | 2011 | 3 | |
| 14 | 2006 | 3 | |
| 15 | 2009 | 3 | |
| 16 | 2009 | 2 | |
| 17 | 2007 | 2 | |
| 18 | 2009 | 2 | |
| 19 | 2010 | 2 | |
| 20 | 1956 | 2 |
About J. Carpenter
J. Carpenter is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Molecular Biology, having authored 23 papers that have together received 716 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (10 papers), Advanced Breast Cancer Therapies (9 papers), Estrogen and related hormone effects (4 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Lung Cancer Research Studies (1 paper), Cancer Genomics and Diagnostics (1 paper) and Biomedical Research and Pathophysiology (1 paper). The work is most often cited by research in Cancer Research (272 citations), Oncology (320 citations), Genetics (199 citations), Pathology and Forensic Medicine (72 citations) and Pulmonary and Respiratory Medicine (115 citations). J. Carpenter has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include R. T. Chlebowski, H.T. Mouridsen, Aman U. Buzdar, Andrea Bianco, Rory Collins, John Crowley, Rosalin Cooper, Francesco Boccardo, Kasper Langebjerg Andersen and Marc Buyse. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, British Journal of Haematology, PubMed and Journal of Allergy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.